2025. Systemic Effects of GLP-1 and Dual GIP/GLP-1 Receptor Agonism in Obesity, Cardiovascular Health, and Neurodegeneration: Review Article. Journal of Pharma Insights and Research. 3, 6 (Dec. 2025), 018–024. DOI:https://doi.org/10.69613/akgbn956.